S. W. Hansen

发表

Gemcitabine in the treatment of ovarian cancer

C. Sessa, S. W. Hansen, M. K. Tuxen, 2001, International Journal of Gynecologic Cancer.

The European Medicines Agency (EMEA) guideline on oncology drug development

Jonas Bergh, S. W. Hansen, Bertil Jonsson, 2007 .

Impaired testicular function in patients with carcinoma-in-situ of the testis.

N. Skakkebaek, M. Ro̸rth, A. Giwercman, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Teniposide (VM-26), an overlooked highly active agent in small-cell lung cancer. Results of a phase II trial in untreated patients.

H. Hansen, M. Hansen, P. Dombernowsky, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High activity of mitoxantrone in previously untreated low-grade lymphomas

N. Nissen, J. Pedersen‐Bjergaard, K. Hou‐Jensen, 2004, Cancer Chemotherapy and Pharmacology.

Patterns of perfusion and ventilation of the lungs in patients with small cell lung cancer before and after combination chemotherapy.

S. Groth, F. Hansen, S. W. Hansen, 1985, Clinical physiology.

Scintigraphy with nanocolloid Tc 99m in patients with small cell lung cancer, with special reference to bone marrow and hepatic metastasis

S. W. Hansen, N. Rossing, A. Widding, 2005, European Journal of Nuclear Medicine.

Detection of liver metastases in small-cell lung cancer: a comparison of peritoneoscopy with liver biopsy and ultrasonography with fine-needle aspiration.

H. Hansen, S. W. Hansen, N. T. Pedersen, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The course of long-term toxicity in patients treated with cisplatin-based chemotherapy for non-seminomatous germ-cell cancer.

S. W. Hansen, P. M. Petersen, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Enhanced pulmonary toxicity in smokers with germ-cell cancer treated with cis-platinum, vinblastine and bleomycin: a long-term follow-up.

M. Ro̸rth, S. Groth, S. W. Hansen, 1989, European journal of cancer & clinical oncology.

Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours

M. Ro̸rth, S. Larsen, J. Pedersen‐Bjergaard, 1991, The Lancet.

Gemcitabine, platinum, and paclitaxel regimens in patients with advanced ovarian carcinoma.

S. W. Hansen, 2002, Seminars in oncology.

Effect of graded testicular doses of radiotherapy in patients treated for carcinoma-in-situ in the testis.

M. Ro̸rth, J. Petersen, A. Giwercman, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Secondary pre-leukaemia and etoposide

M. Ro̸rth, S. Larsen, J. Pedersen‐Bjergaard, 1991, The Lancet.

Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin for germ cell cancer: measurement of vasoconstrictor response to cold.

S. W. Hansen, N. Olsen, Niels Olsen, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term effects on renal function and blood pressure of treatment with cisplatin, vinblastine, and bleomycin in patients with germ cell cancer.

M. Ro̸rth, S. Groth, G. Daugaard, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ventilation/perfusion relations in patients with small cell anaplastic carcinoma of the lung, obtaining complete remission during combination chemotherapy.

S. Groth, S. W. Hansen, P. Sørensen, 1984, European journal of cancer & clinical oncology.

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study.

P. Albers, M. Moore, I. Bodrogi, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-Term Toxicity after Cisplatinum-Based Chemotherapy

M. Ro̸rth, G. Daugaard, S. W. Hansen, 1994 .

Vascular toxicity and the mechanism underlying Raynaud's phenomenon in patients treated with cisplatin, vinblastine and bleomycin.

M. Ro̸rth, S. W. Hansen, N. Rossing, 1990, Annals of oncology : official journal of the European Society for Medical Oncology.

Dose-dependent impairment of testicular function in patients treated with cisplatin-based chemotherapy for germ cell cancer.

N. Skakkebaek, M. Ro̸rth, A. Giwercman, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Long-term fertility and Leydig cell function in patients treated for germ cell cancer with cisplatin, vinblastine, and bleomycin versus surveillance.

H. von der Maase, S. W. Hansen, J. Berthelsen, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Autonomic neuropathy after treatment with cisplatin, vinblastine, and bleomycin for germ cell cancer.

S. W. Hansen, 1990, BMJ.

Long-term neurotoxicity in patients treated with cisplatin, vinblastine, and bleomycin for metastatic germ cell cancer.

W. Trojaborg, S. Helweg-Larsen, S. W. Hansen, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Two Subtypes of Therapy-Related Leukemia; Experience from The Copenhagen Series

S. Larsen, J. Pedersen‐Bjergaard, L. Specht, 1994 .

Phase I study of the cisplatin analogue 1,1-diamminomethylcyclohexane sulfatoplatinum (TNO-6) (NSC 311056)

H. Hansen, M. Ro̸rth, J. Sørensen, 2004, Cancer Chemotherapy and Pharmacology.

Impaired T esticular F unction i n P atients With C arcinoma-In-Sit u o f t he T estis

N. Skakkebaek, M. Ro̸rth, A. Giwercman, 1999 .

Neurotoxicity secondary to antineoplastic drugs.

S. W. Hansen, M. Tuxen, 1994, Cancer treatment reviews.

S. Larsen, J. Pedersen‐Bjergaard, K. Hou‐Jensen, 1993, Leukemia.

N. Nissen, J. Pedersen‐Bjergaard, S. W. Hansen, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Second occurrence of symptomatic metastatic spinal cord compression and findings of multiple spinal epidural metastases.

P. Sørensen, S. Helweg-Larsen, S. W. Hansen, 1995, International Journal of Radiation Oncology, Biology, Physics.

Comparison of rhG–CSF primed bone marrow and blood stem cell autografts: an analysis of engraftment in malignant lymphomas and solid tumours

H. Johnsen, L. Knudsen, F. Hansen, 1998, European journal of haematology.

Treatment of persistent or relapsing advanced germ cell neoplasms with cisplatin, etoposide and bleomycin.

M. Ro̸rth, G. Daugaard, S. W. Hansen, 1986, European journal of cancer & clinical oncology.

Gonadal function in men with testicular germ cell cancer: the influence of cisplatin-based chemotherapy.

S. W. Hansen, P. Hansen, 1993, European urology.

Testicular cancer after vasectomy: origin from carcinoma in situ of the testis.

N. Skakkebaek, N. Jørgensen, A. Giwercman, 1993, European journal of cancer.

Severe neurotoxicity caused by gemcitabine treatment

S. W. Hansen, F. Larsen, 2004, Acta oncologica.

[High-dose chemotherapy and autologous bone marrow transplantation in solid tumors. A review].

S. W. Hansen, J. Handberg, 1996, Ugeskrift for laeger.

Acute and Late Toxicity Following Adjuvant High-Dose Chemotherapy for High-Risk Primary Operable Breast Cancer A Quality Assessment Study

H. Johnsen, I. Svane, S. W. Hansen, 2002, Acta oncologica.

Lung abscess in small cell carcinoma of the lung during chemotherapy and corticosteroids: an analysis of 276 consecutive patients.

S. W. Hansen, K. Aabo, K. Osterlind, 1986, European journal of respiratory diseases.

Real-world evidence to guide healthcare policies in oncology

M. Donia, I. Svane, S. W. Hansen, 2019, Oncotarget.

Paclitaxel (175 mg/m2 over 3 hours) with cisplatin or carboplatin in previously untreated ovarian cancer: an interim analysis.

H. V. van Houwelingen, H. V. Houwelingen, F. Hirsch, 1997, Seminars in oncology.

Gemcitabine in the treatment of ovarian cancer

S. W. Hansen, S. W. Hansen, 2001, International Journal of Gynecologic Cancer.

Long-Term Results on Mitoxantrone Treatment in Patients with Low-Grade Non-Hodgkin’s Lymphomas

N. Nissen, S. W. Hansen, 1994 .

Latamoxef versus carbenicillin plus gentamicin or carbenicillin plus mecillinam in leukopenic, febrile patients with solid tumors.

S. W. Hansen, R. Vejlsgaard, H. Friis, 2009, Acta medica Scandinavica.

High activity of daily-schedule mitoxantrone in newly diagnosed low-grade non-Hodgkin's lymphomas: a 5-year follow-up.

N. Nissen, S. W. Hansen, 1990, Seminars in oncology.

I. Bodrogi, P. Conte, L. Dogliotti, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Late-effects after treatment for germ-cell cancer with cisplatin, vinblastine, and bleomycin.

S. W. Hansen, 1992, Danish medical bulletin.

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study.

I. Bodrogi, P. Conte, H. von der Maase, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I trial of 1,2,4-triglycidylurazol (TGU, NSC 332488): a new triepoxide cytostatic agent.

F. Cavalli, H. Hansen, S. W. Hansen, 1985, European journal of cancer & clinical oncology.

Comments on Economic Evaluation of Chemotherapy

H. Keiding, H. Mouridsen, B. Christensen, 1997, PharmacoEconomics.